NEW YORK, March 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Natera, Inc. (“Natera”) (NASDAQ:NTRA) pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company’s Initial Public Offering on July 2, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the Superior Court of the State of California, County of San Mateo. If you purchased or otherwise acquired Natera securities pursuant to the IPO, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/natera-ntra.
The complaint alleges that Natera’s Registration Statement, filed in connection with the IPO, contained misleading information and/or omitted material information that presented a positive outlook for Natera’s business, performance, prospects and products, while omitting significant facts and known trends that had already unfavorably impacted Natera’s revenues and net losses at the time of the IPO.
On July 2, 2015, Natera went public with an IPO price of $18 per share. Since the IPO, shares of Natera have fallen to a close of just $7.00 per share as recently as February 12, 2016.
If you suffered a loss in Natera and would like to obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/natera-ntra.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



